ADMA Biologics Inc vs SpaceX — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.22B), while SpaceX trades at $134.85 (market cap $1.76T). The key difference: SpaceX is far larger — about 792.8× ADMA Biologics Inc's market cap, and SpaceX is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | SPCX | |
|---|---|---|
Market Cap | $2.22B | $1.76T |
Sector | Health | Technology |
52-Week High | $20.38 | $202.09 |
52-Week Low | $7.60 | $108.27 |
Enterprise Value | $2.29B | $1.70T |
Trailing returns across standard periods
Latest headlines on both assets
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →